MedPath

Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications

Not Applicable
Completed
Conditions
Schizophrenia
Interventions
Behavioral: Exercise program
Behavioral: Diet
Registration Number
NCT01409590
Lead Sponsor
Sheba Medical Center
Brief Summary

In this study the investigators will recruit patients with the diagnosis of schizophrenia that are taking atypical neuroleptics and that are willing to participate in an exercise and diet program. The investigators will measure weight and abdomen circumference.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Schizophrenia
  • Atypical neuroleptics
Exclusion Criteria
  • Medical illness preventing exercise

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Exercise and Diet programExercise programAll patients recruited in the study, participated in an homogeneous exercise program and diet.
Exercise and Diet programDietAll patients recruited in the study, participated in an homogeneous exercise program and diet.
Primary Outcome Measures
NameTimeMethod
Weight lossOne year

The weight of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Secondary Outcome Measures
NameTimeMethod
Abdomen circumferenceOne year

The circumference of the abdomen of the participants of the trial was monitored during the trial, while they were following the exercise program and the diet, starting from the baseline until end of study/early withdrawal.

Trial Locations

Locations (1)

Sheba Medical Center

🇮🇱

Tel Hashomer, Ramat Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath